|
|
商品名 |
|
|
商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。
|
Becenun |
巴西 |
Bicnu |
伊朗, 加拿大, 匈牙利, 哥伦比亚, 墨西哥, 希腊, 摩洛哥, 新西蘭, 智利, 法国, 澳大利亚, 爱尔兰, 瑞士, 秘鲁, 突尼斯, 罗马尼亚, 美国, 英国, 西班牙 |
Bodacler |
阿根廷 |
Carmubris |
伊朗, 奥地利, 德国 |
Carmustina Grey |
秘鲁 |
Carmustina Perulab |
秘鲁 |
Carmustine Baxter |
新西蘭 |
Carmustine Obvius |
丹麦, 保加利亚, 克罗地亚, 冰岛, 匈牙利, 卢森堡, 奥地利, 德国, 挪威, 捷克共和國, 斯洛伐克, 斯洛文尼亚, 比利时, 法国, 波兰, 爱尔兰, 瑞典, 罗马尼亚, 芬兰, 英国, 荷兰, 葡萄牙, 西班牙 |
Nitrourean |
西班牙 |
Nitrumon |
伊朗, 卢森堡, 比利时 |
|
|
|
|
引用文献 : Carmustine |
|
|
种类 |
出版物 |
3 |
文献 |
Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
81 |
文献 |
Trissel LA, Martinez JF. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 672-678. |
84 |
文献 |
Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499. |
99 |
文献 |
Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090. |
146 |
文献 |
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M. Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine. Clin Ther 1992 ; 14: 821-824. |
169 |
文献 |
Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363. |
182 |
文献 |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60. |
244 |
文献 |
Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913. |
249 |
文献 |
Trissel LA, Martinez JF. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1996 ; 53: 1041-1045. |
307 |
文献 |
Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799. |
334 |
文献 |
Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992. |
335 |
文献 |
Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406. |
492 |
文献 |
Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189. |
715 |
文献 |
Colvin M, Hartner J, Summerfield M. Stability of carmustine in the presence of sodium bicarbonate. Am J Hosp Pharm 1980 ; 37: 677-678. |
837 |
文献 |
Fredriksson K, Lundgren P, Landersjo L. Stability of carmustine - kinetics and compatibility during administration. Acta Pharm Suec 1986 ; 23: 115-124. |
905 |
文献 |
Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017. |
1410 |
文献 |
Trissel LA, Martinez JF, Simmons M. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 141-145. |
1423 |
文献 |
Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518. |
1501 |
文献 |
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121. |
1520 |
实验室 |
Etude de stabilité des médicaments en Ecoflac® B Braun 2001 |
1622 |
文献 |
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F. Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers. Am J Health-Syst Pharm 2001 ; 58: 238-241. |
2146 |
文献 |
Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382. |
3314 |
实验室 |
Carmustine (Bicnu®) – Résumé des caractéristiques du produits Bristol Myers Squibb 2011 |
4762 |
文献 |
Knoll L, Kraemer I, Thiesen J. Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature EJHP 2023 ; 30, 1: 11-16. |
|
|